Has Satheesh Chonat received payments from drug or device companies?

Yes. Drug and device makers reported $146,831 in general payments to Satheesh Chonat across 118 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Satheesh Chonat did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Satheesh Chonat come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Satheesh Chonat

Pediatrics · Atlanta, GANPI 1639300544

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $94,038 of the $146,831 with a category attached, or 64.0%. 11 manufacturers reported payments, led by AstraZeneca at 45.0% of the total. 2025 is the largest year on record at $54,609, more than ten times the $4,141 reported in 2019. Among pediatrics clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$146,831in general payments, 2019–2025

Across 118 payments — averaging $1244.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$66K
Octapharma USA, Inc.$19K
Novartis$17K
Agios Pharmaceuticals, Inc.$14K
Takeda Pharmaceuticals U.S.A., Inc.$10K
F. Hoffmann-la Roche AG$8K
plus $12K from 5 others

$1,155,617in research payments, 2019–2025

Across 88 payments — averaging $13,132 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Agios Pharmaceuticals, Inc.$453K
AstraZeneca$363K
Amgen$207K
Genentech, Inc.$113K
Sanofi US Services Inc.$14K
Novartis$6K

What the payments were for

Consulting fees$94,03864%
Speaking & faculty fees$12,0208%
Travel & lodging$36,89925%
Food & beverage$3,8743%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	58	$66,034
Octapharma USA, Inc.	5	$19,193
Novartis	6	$17,341
Agios Pharmaceuticals, Inc.	27	$13,980
Takeda Pharmaceuticals U.S.A., Inc.	3	$9,929
F. Hoffmann-la Roche AG	8	$8,107
Novo Nordisk	2	$5,015
Samsung Bioepis Co., Ltd.	2	$3,070
Amgen	4	$2,075
Daiichi Sankyo Inc.	1	$1,800
Apellis Pharmaceuticals, Inc.	2	$287

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

PYRUKYND$12,894
ULTOMIRIS$9,138
SOLIRIS$4,100
ADAKVEO$1,830
INJECTAFER$1,800

How this compares

$146,831 in reported general payments places this provider in the 95th percentile of 2,111 pediatrics providers in Georgia.

See all pediatrics providers in Georgia →

Other pediatrics in Atlanta

Amir AshrafiAtlanta$563K
Karen ZimowskiAtlanta$139K
Iyabode Akinsanya-BeysolowAtlanta$103K
Lauren MiddlebrooksAtlanta$71K
Rebecca EmoryAtlanta$40K
Mark GriffithsAtlanta$34K
Kelly TickleAtlanta$29K
Robert WiskindAtlanta$21K
Mary BertossiAtlanta$20K
Josette AbeytaAtlanta$19K

See the full list for Georgia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →